This review discusses evaluation and treatment of neuro-ophthalmic disorders in the pregnant patient.
Any neuro-ophthalmic abnormality seen in nonpregnant women can be seen in pregnant women. Pregnancy-specific complications (preeclampsia and eclampsia) cause visual symptoms and can affect the entire visual axis.
Appropriate evaluation and examination is important to preserve the health and vision of the mother and prevent complications in the fetus. Evaluation should proceed in the same way for a pregnant patient as it would for a nonpregnant patient, with few exceptions. Treatment decisions may be influenced by stage of pregnancy.
Address correspondence to Dr Kathleen Digre, Moran Eye Center, University of Utah, 65 Mario Capecchi Drive, Salt Lake City, UT 84132, Kathleen.email@example.com.
Relationship Disclosure: Dr Digre has received a grant from the National Eye Institute and salary support from the Neuro-ophthalmology Research/Disease Investigator Consortium. Dr Kinard reports no disclosure.
Unlabeled Use of Products/Investigational Use Disclosure: Drs Digre and Kinard discuss the use of several drugs for the treatment of neuro-ophthalmic disorders, none of which are labeled by the US Food and Drug Administration for use in pregnancy.